Markets:

Overview

News

Currencies

International

Treasuries

Gamida Cell Ltd. - Ordinary Shares (NQ:GMDA)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 5, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Gamida Cell Ltd. - Ordinary Shares

< Previous 1 2 3 4 Next >

Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket ↗

September 28, 2022

Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday.

Via Benzinga

Recap: Gamida Cell Q2 Earnings ↗

August 15, 2022

Gamida Cell (NASDAQ:GMDA) reported its Q2 earnings results on Monday, August 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 01, 2022

Via Benzinga

FDA Accepts Gamida's Filing For Stem Cell Transplant Candidate Under Priority Review ↗

August 01, 2022

The U.S. Food and Drug Administration (FDA) has accepted for filing the Gamida Cell’s (NASDAQ: GMDA) Biologics License Application (BLA) for omidubicel in the treatment of patients with blood cancers...

Via Benzinga

Gamida Cell Posts Updated Omidubicel Data In Blood Cancer Patients ↗

April 27, 2022

Via Benzinga

Gamida Cell Shares Jump On FDA Nod To Cell Therapy Trial In Blood Cancer Settings ↗

April 26, 2022

Via Benzinga

Gamida Cell: Q4 Earnings Insights ↗

March 15, 2022

Gamida Cell (NASDAQ:GMDA) reported its Q4 earnings results on Tuesday, March 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Earnings Scheduled For August 15, 2022 ↗

August 15, 2022

Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.

Via Benzinga

Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday ↗

August 12, 2022

Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results.

Via Benzinga

Cell Therapy-Focused Gamida Plans To Cut 10% Of Staff ↗

January 31, 2022

Gamida Cell Ltd (NASDAQ: GMDA) will terminat

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

July 25, 2022

On Monday, 100 companies reached new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

July 22, 2022

During Friday's session, 61 companies made new 52-week lows.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

June 16, 2022

It's time for another breakdown of the biggest pre-market stock movers as we go over the latest news for Thursday morning.

Via InvestorPlace

27 Stocks Moving in Thursday's Pre-Market Session ↗

June 16, 2022

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) rose 92.9% to $3.28 in pre-market trading following’s Wednesday IPO.

Via Benzinga

The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves ↗

May 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Gamida Cell: Q1 Earnings Insights ↗

May 10, 2022

Gamida Cell (NASDAQ:GMDA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Gamida Cell reported in-line EPS of...

Via Benzinga

Earnings Preview: Gamida Cell ↗

May 09, 2022

Gamida Cell (NASDAQ:GMDA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Gamida Cell will...

Via Benzinga

The Daily Biotech Pulse - Tuesday, April,26 ↗

April 26, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Talk Markets

The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track Tag For Vascular Biogenics Ovarian Cancer Gene Therapy ↗

April 26, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial ↗

March 15, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For March 15, 2022 ↗

March 15, 2022

Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi...

Via Benzinga

Preview: Gamida Cell's Earnings ↗

March 14, 2022

Gamida Cell (NASDAQ:GMDA) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement. Analysts estimate...

Via Benzinga

Merck (MRK) Outperforms Industry, What's In Store For 2022? ↗

March 07, 2022

Merck boasts more than six blockbuster drugs in its portfolio with PD-L1 inhibitor, Keytruda, approved for several types of cancer, alone accounting for around 40% of its pharmaceutical sales.

Via Talk Markets

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings ↗

March 13, 2022

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...

Via Benzinga

Gamida Cell Shares Surge On Rolling Omidubicel Marketing Application In US ↗

February 09, 2022

Gamida Cell Ltd (NASDAQ: GMDA) has initiated the Biologics License Application (BLA)

Via Benzinga

48 Biggest Movers From Yesterday ↗

January 21, 2022

Gainers Aptorum Group Limited (NYSE: APM) shares jumped 38.5% to close at $1.69 on Thursday after the company announced it received FDA Orphan Drug designation for...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

January 20, 2022

Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 29.8% to $0.2550. Baudax Bio, last month, announced a $4.2 million registered direct offering. Vertical Aerospace Ltd. (NYSE...

Via Benzinga

Hot Penny Stocks: What’s Moving VVOS, GMDA and SBEV Higher Today? ↗

January 19, 2022

Several penny stocks are on the move Wednesday and we're diving into the hot news behind that momentum with a quick dive into the space.

Via InvestorPlace

35 Stocks Moving In Wednesday's Mid-Day Session ↗

January 19, 2022

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for approximately $1.9 billion. Splash Beverage Group,...

Via Benzinga

52 Biggest Movers From Yesterday ↗

January 20, 2022

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion. G...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Gamida Cell Ltd. - Ordinary Shares (NQ:GMDA)

Headline News about Gamida Cell Ltd. - Ordinary Shares

Starting at $3.75/week.

Subscribe Today